Detalhe da pesquisa
1.
Equivalent thrombotic risk with Warfarin, Dabigatran, or Enoxaparin after failure of initial direct oral anticoagulation (DOAC) therapy.
J Thromb Thrombolysis
; 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643437
2.
Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression.
Int J Mol Sci
; 25(7)2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612873
3.
An overlooked mimic? Autoimmune myelofibrosis-A scoping review of the literature.
Eur J Haematol
; 111(5): 706-714, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515415
4.
Exclusion of Acute Myeloid Leukemia Patients with Central Nervous System Involvement from Clinical Trials: An Analysis of the National Institutes of Health Clinical Trials Registry from 2012-2022.
Acta Haematol
; : 1, 2023 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751713
5.
New Treatments for Myelofibrosis.
Curr Treat Options Oncol
; 24(2): 61-75, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640223
6.
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.
Blood
; 135(19): 1696-1703, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107559
7.
Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions.
Ann Hematol
; 101(5): 935-951, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344066
8.
Momelotinib for the treatment of myelofibrosis with anemia.
Future Oncol
; 18(20): 2559-2571, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603634
9.
Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia.
Oncologist
; 26(5): 406-421, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792103
10.
Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort study.
J Med Virol
; 93(2): 907-915, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32706392
11.
Emerging drugs for the treatment of myelofibrosis: phase II & III clinical trials.
Expert Opin Emerg Drugs
; 26(4): 351-362, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875179
12.
The utility of thrombophilia and hematologic screening in live liver donation.
Clin Transplant
; 35(1): e14159, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33222303
13.
The Efficacy of Etoposide-Based Therapy in Adult Secondary Hemophagocytic Lymphohistiocytosis.
Acta Haematol
; 144(5): 560-568, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33827086
14.
Clinical Benefit Derived from Decitabine Therapy for Advanced Phases of Myeloproliferative Neoplasms.
Acta Haematol
; 144(1): 48-57, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32160610
15.
Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
Dig Dis Sci
; 66(10): 3619-3629, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33151401
16.
The Impact of Socioeconomic Status on the Clinical Outcomes of COVID-19; a Retrospective Cohort Study.
J Community Health
; 46(4): 794-802, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387149
17.
Modern management of splenomegaly in patients with myelofibrosis.
Ann Hematol
; 99(7): 1441-1451, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32417942
18.
Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.
Eur J Haematol
; 104(4): 344-351, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31991015
19.
Soluble interleukin-2 receptor (sIL-2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.
Eur J Haematol
; 105(3): 255-261, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32353917
20.
Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation.
J Thromb Thrombolysis
; 50(3): 652-660, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034618